1.
Emerg Infect Dis
; 25(11): 2145-2147, 2019 11.
Artículo
en Inglés
| MEDLINE
| ID: mdl-31625858
RESUMEN
Antibodies against PD1 have been used to treat progressive multifocal leukoencephalopathy (PML), a rare brain disease caused by JC virus. We used these antibodies (nivolumab) to treat PML in 3 kidney transplant recipients. All died within 8 weeks of diagnosis. Hence, nivolumab did not improve PML outcome after solid organ transplantation.